Stada Arzneimittel AG - Company Profile

Powered by

All the data and insights you need on Stada Arzneimittel AG in one report.

  • Save hours of research time and resources with
    our up-to-date Stada Arzneimittel AG Strategy Report

  • Understand Stada Arzneimittel AG position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Stada Arzneimittel AG: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Stada Arzneimittel AG (STADA), a subsidiary of Nidda Healthcare GmbH, is a manufacturer of low-cost generics and branded over-the-counter products. The company develops and markets drugs with off-patent active pharmaceutical ingredients, particularly, which are free from commercial property rights. The company offers portfolio of products in various therapeutic categories including pain, women's health, cardiovascular conditions and diabetes. Few of its major generic products include including Tilidin Naloxon, Atorvastatin and Epoetin zeta. Its major branded products include APO-Go, Grippostad, Snup and Fultium. The company operates across Germany, Central Europe, CIS/Eastern Europe and Asia-Pacific. STADA is headquartered in Bad Vilbel, Germany.

Gain a 360-degree view of Stada Arzneimittel AG and make more informed decisions for your business Gain a 360-degree view of Stada Arzneimittel AG and make more informed decisions for your business Find out more
Headquarters Germany

Address Stadastrasse 2-18, Bad Vilbel, Hessen, 61118


Telephone 49 6101 6030

No of Employees 13,183

Industry Pharmaceuticals and Healthcare

Revenue (2022) $4.0B

   

   

Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Stada Arzneimittel AG premium industry data and analytics

720+

Marketed Drugs

Understand Stada Arzneimittel AG’s commercialized product portfolio to stay one step ahead of the market.

190+

Clinical Trials

Determine Stada Arzneimittel AG go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

20+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Stada Arzneimittel AG’s relevant decision makers and contact details.

18+

Catalyst Calendar

Proactively evaluate Stada Arzneimittel AG’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

11+

Pipeline Drugs

Identify which of Stada Arzneimittel AG’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

7

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

6

Sales & Consensus Forecasts

Understand the current and future drug revenue for Stada Arzneimittel AG and assess market opportunity for new entrants with patient population 8-year forecasts.

4

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

3

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Stada Arzneimittel AG (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

Products and Services

Products Brands
Generic: Zoflora
Unbranded and Branded Generics Snup
Speciality Pharmaceuticals Nizoral
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Stada Arzneimittel AG portfolio and identify potential areas for collaboration Understand Stada Arzneimittel AG portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Contracts/Agreements In July, the company signed an agreement to acquire Sanofi consumer healthcare brands across several countries, including Belgium, Germany, Hungary, Spain and the UK, as well as Nordic countries.
2023 Regulatory Approval In June, the company received approval from U.S. FDA for biologics facility to supply key medicines to patients in the US.
2023 Contracts/Agreements In May, the company entered into agreements with Alvotech SA to terminate the license and supply agreements between Alvotech and STADA pertaining to Alvotech's product candidates AVT03, AVT05 and AVT16.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Stada Arzneimittel AG Evotec SE Biotest AG MPA Pharma GmbH MorphoSys AG
Headquarters Germany Germany Germany Germany Germany
City Bad Vilbel Hamburg Dreieich Trittau Planegg
State/Province Hessen Baden-Wurttemberg Hessen Schleswig-Holstein Bayern
No. of Employees 13,183 5,055 2,426 470 464
Entity Type Private Public Public Private Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Executives
Name Position Board Since Age
Günter von Au Chairman Executive Board 2017 72
Peter Goldschmidt Chief Executive Officer Senior Management 2018 -
Miguel Pagan Fernandez Chief Technical Officer Senior Management 2018 -
Simone Berger Chief Human Resources Officer Senior Management 2021 -
Markus Damm Deputy Chairman Executive Board 2019 52
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Stada Arzneimittel AG key executives to enhance your sales strategy Gain insight into Stada Arzneimittel AG key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer